Tassignon Marie-José, Van den Heurck Jonas J I, Boven Kim B M, Van Looveren Jan, Wouters Kristien, Bali Ernesto, Ní Dhubhghaill Sorcha, Mathysen Danny G P
From the Department of Ophthalmology (Tassignon, Van den Heurck, Boven, Van Looveren, Dhubhghaill, Mathysen) Antwerp University Hospital, Edegem, Antwerp, Belgium; Faculty of Medicine and Health Sciences (Tassignon, Van den Heurck, Boven, Jan Van Looveren, Wouters, Mathysen), University of Antwerp, Wilrijk, Antwerp, Belgium; Department of Scientific Coordination-Biostatistics (Wouters), Antwerp University Hospital, Edegem, Antwerp, Belgium; Department of Ophthalmology (Bali), Clinique du Parc Léopold, Brussels, Belgium.
From the Department of Ophthalmology (Tassignon, Van den Heurck, Boven, Van Looveren, Dhubhghaill, Mathysen) Antwerp University Hospital, Edegem, Antwerp, Belgium; Faculty of Medicine and Health Sciences (Tassignon, Van den Heurck, Boven, Jan Van Looveren, Wouters, Mathysen), University of Antwerp, Wilrijk, Antwerp, Belgium; Department of Scientific Coordination-Biostatistics (Wouters), Antwerp University Hospital, Edegem, Antwerp, Belgium; Department of Ophthalmology (Bali), Clinique du Parc Léopold, Brussels, Belgium.
J Cataract Refract Surg. 2015 Nov;41(11):2430-7. doi: 10.1016/j.jcrs.2015.05.026.
To determine the incidence of rhegmatogenous retinal detachment (RRD) and associated risk factors after phacoemulsification and bag-in-the-lens intraocular lens (IOL) implantation.
Antwerp University Hospital, Department of Ophthalmology, Antwerp, Belgium.
Prospective cohort study.
All consecutive bag-in-the-lens IOL implantations performed between January 2001 and December 2007 were included, with the exception of combined procedures and IOL exchanges. The retinal detachment (RD) incidence was studied in the total cohort, in a subgroup of patients with 1 to 5 years of follow-up, and finally in the group remaining after exclusion of all risk factors except gender.
RD after bag-in-the-lens IOL implantation in 1323 eyes with an average follow-up of 44.75 months (range 0 to 152 months) was found in 19 eyes (1.44%). The 1-year RD incidence was 0.49% (5 RD cases in 1024 eyes) (0.00% in patients without risk factors). The 2-year cumulative RD incidence was 0.84% (9 RD cases in 931 eyes; 0.15% without risk factors). Four clinically significant risk factors were confirmed: male gender, young age at time of surgery (<60 years), axial myopia (axial length ≥25 mm), and history of contralateral RD in the total cohort.
The RRD incidence following bag-in-the-lens IOL implantation was comparable to that seen after lens-in-the-bag (LIB) implantation. The wide variation in study design in the literature precludes direct comparison, so there is a need for standardization in evaluating RRD incidence after cataract surgery. Future prospective studies should consider patients with and without risk factors (except gender) separately.
Prof. dr. M.J. Tassignon has intellectual property rights to the bag-in-the-lens intraocular lens (U.S. patent 6 027 531; EU patent 009406794; PCT/120268), which is licensed to Morcher GmbH, Stuttgart, Germany.
确定白内障超声乳化吸除联合囊内人工晶状体(IOL)植入术后孔源性视网膜脱离(RRD)的发生率及相关危险因素。
比利时安特卫普大学医院眼科
前瞻性队列研究
纳入2001年1月至2007年12月期间连续进行的所有囊内IOL植入手术,但不包括联合手术和IOL置换手术。在整个队列、随访1至5年的患者亚组以及排除除性别外所有危险因素后剩余的组中研究视网膜脱离(RD)的发生率。
1323只眼平均随访44.75个月(范围0至152个月),囊内IOL植入术后发生RD的有19只眼(1.44%)。1年RD发生率为0.49%(1024只眼中有5例RD)(无危险因素患者为0.00%)。2年累积RD发生率为0.84%(931只眼中有9例RD;无危险因素患者为0.15%)。在整个队列中确认了4个具有临床意义的危险因素:男性、手术时年龄较轻(<60岁)、轴性近视(眼轴长度≥25mm)以及对侧RD病史。
囊内IOL植入术后RRD发生率与囊袋内人工晶状体(LIB)植入术后相当。文献中研究设计差异很大,无法进行直接比较,因此在评估白内障手术后RRD发生率时需要标准化。未来的前瞻性研究应分别考虑有和无危险因素(性别除外)的患者。
M.J. Tassignon教授拥有囊内人工晶状体的知识产权(美国专利6 027 531;欧盟专利009406794;PCT/120268),该专利已授权给德国斯图加特的Morcher GmbH公司。